Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China · Delayed Price · Currency is CNY 50.48
-0.07 (-0.14%)
Aug 31, 2026, 3:04 PM CST
Betta Pharmaceuticals Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Revenue | 3,825 | 3,578 | 2,827 | 2,417 | 2,342 | 2,206 |
Other Revenue | 28.64 | 31.67 | 64.95 | 39.41 | 34.18 | 40.05 |
| 3,854 | 3,609 | 2,892 | 2,456 | 2,377 | 2,246 | |
Revenue Growth | 23.42% | 24.81% | 17.74% | 3.35% | 5.82% | 20.08% |
Cost of Revenue | 878.46 | 738.66 | 538.52 | 404.48 | 268.69 | 174.44 |
Gross Profit | 2,975 | 2,871 | 2,353 | 2,052 | 2,108 | 2,071 |
Selling, General & Admin | 1,813 | 1,779 | 1,363 | 1,116 | 1,234 | 1,141 |
Research & Development | 473.14 | 510.87 | 501.9 | 640.14 | 699.9 | 565.95 |
Other Operating Expenses | 74.54 | 40.88 | 18.19 | 10.62 | -34.51 | 15.24 |
Operating Expenses | 2,365 | 2,330 | 1,876 | 1,772 | 1,901 | 1,723 |
Operating Income | 609.95 | 540.45 | 476.96 | 279.88 | 206.96 | 348.77 |
Interest Expense | -73.72 | -76.14 | -45.49 | -54.95 | -195.8 | -15.78 |
Interest & Investment Income | 2.24 | 4.29 | 6.78 | 10.23 | 10.88 | 33.35 |
Currency Exchange Gain (Loss) | -27.9 | -12.62 | 4.14 | 6.72 | 9.55 | -3.63 |
Other Non Operating Income (Expenses) | -3.16 | -1.19 | -6.57 | -4.96 | -9 | -0.84 |
EBT Excluding Unusual Items | 507.42 | 454.79 | 435.82 | 236.92 | 22.59 | 361.88 |
Impairment of Goodwill | -29.93 | - | - | - | - | - |
Gain (Loss) on Sale of Investments | 48.48 | -79.33 | -40.97 | -13.67 | -20.62 | 1.01 |
Gain (Loss) on Sale of Assets | -0.04 | 0.38 | -0.59 | -0.01 | 88.61 | 0.07 |
Asset Writedown | -0.01 | -0.01 | -28.05 | -1.07 | -3.01 | -0.03 |
Other Unusual Items | 68.95 | 38.53 | 27.95 | 99.9 | - | 27.01 |
Pretax Income | 594.86 | 414.36 | 394.16 | 322.07 | 87.57 | 389.93 |
Income Tax Expense | 146.67 | 128.15 | 7.18 | -11.54 | -37.19 | 10.37 |
Earnings From Continuing Operations | 448.19 | 286.21 | 386.98 | 333.62 | 124.76 | 379.56 |
Minority Interest in Earnings | 19.37 | 19.12 | 15.59 | 14.42 | 20.66 | 3.51 |
Net Income | 467.57 | 305.33 | 402.57 | 348.03 | 145.42 | 383.07 |
Net Income to Common | 467.57 | 305.33 | 402.57 | 348.03 | 145.42 | 383.07 |
Net Income Growth | 46.79% | -24.15% | 15.67% | 139.33% | -62.04% | -36.83% |
Shares Outstanding (Basic) | 416 | 418 | 419 | 419 | 416 | 416 |
Shares Outstanding (Diluted) | 419 | 418 | 419 | 419 | 416 | 416 |
Shares Change | -1.15% | -0.26% | 0.01% | 0.72% | -0.02% | 2.32% |
EPS (Basic) | 1.12 | 0.73 | 0.96 | 0.83 | 0.35 | 0.92 |
EPS (Diluted) | 1.12 | 0.73 | 0.96 | 0.83 | 0.35 | 0.92 |
EPS Growth | 48.50% | -23.96% | 15.66% | 137.47% | -62.01% | -38.26% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 267.32 | 294.58 | 83.58 | -181.79 | -703.8 | -231.75 |
Free Cash Flow Per Share | 0.64 | 0.70 | 0.20 | -0.43 | -1.69 | -0.56 |
Dividend Per Share | 0.150 | 0.150 | 0.200 | 0.170 | 0.070 | 0.250 |
Dividend Growth | -25.00% | -25.00% | 17.65% | 142.86% | -72.00% | -19.36% |
Gross Margin | 77.21% | 79.53% | 81.38% | 83.53% | 88.69% | 92.23% |
Operating Margin | 15.83% | 14.97% | 16.49% | 11.39% | 8.71% | 15.53% |
Profit Margin | 12.13% | 8.46% | 13.92% | 14.17% | 6.12% | 17.06% |
Free Cash Flow Margin | 6.94% | 8.16% | 2.89% | -7.40% | -29.61% | -10.32% |
EBITDA | 1,167 | 1,088 | 845.1 | 578.14 | 453.58 | 517.89 |
EBITDA Margin | 30.28% | 30.15% | 29.22% | 23.54% | 19.09% | 23.06% |
D&A For EBITDA | 556.88 | 547.93 | 368.14 | 298.26 | 246.62 | 169.12 |
EBIT | 609.95 | 540.45 | 476.96 | 279.88 | 206.96 | 348.77 |
EBIT Margin | 15.83% | 14.97% | 16.49% | 11.39% | 8.71% | 15.53% |
Effective Tax Rate | 24.66% | 30.93% | 1.82% | - | - | 2.66% |
Revenue as Reported | 3,854 | 3,609 | 2,892 | 2,456 | 2,377 | 2,246 |
Advertising Expenses | - | - | - | - | 414.75 | 459.29 |